One of the receptors responsible for the activation of the NK cells, NKG2D (NCBI symbol KLRK1) receptor, is implicated in interaction of NK cells with senescent cells during tumorigenesis and tumor therapy [26, 27]. This evidence concerns the gene KLRK1 and neoplasm.